A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M

Japan’s Regcell launches in US with $45.8M to advance Treg platform

Chutes & Ladders—Google DeepMind vet to join GSK as VP of artificial intelligence

Co-founded by David Baker, Vilya rings in a permanent CEO; Allogene names Eric Schmidt’s CFO successor

Up and down the ladder: The latest comings and goings

RegCell Hires Michael McCullar as CEO

RegCell Appoints Experienced Life Science Executive and Entrepreneur Michael McCullar, Ph.D., MBA, as its New Chief Executive Officer